IDBS Acquires InforSense to Provide End-to-End Solutions for R&D Data Management
News Jun 29, 2009
IDBS has announced that it has concluded an unconditional agreement to acquire InforSense Ltd (InforSense), a company providing scientific and business intelligence (BI) technologies, in an all-cash transaction. The acquisition will complete in July.
R&D organizations in the public and private sectors rely upon their ability to capture, integrate and interpret their data. This is hampered by the explosion in volume and diversity of data available to scientists, the global scale of modern R&D activities and the requirement for data to be accessed and searched in context.
InforSense’s data integration technologies and web-based interactive analytics complement IDBS’ suite of secure, context-rich data management solutions. This transaction creates a supplier who can deliver the entire capture, integration and decision-making infrastructure for R&D organizations worldwide.
With the addition of the InforSense product portfolio, IDBS will expand its large scale data integration activities to support international data sharing and broaden its life sciences portfolio into the emerging growth area of biomarker development and personalized medicine.
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
The architecture of each person’s brain is unique, and differences may influence how quickly people can complete various cognitive tasks.o learn more, scientists are developing a new tool — computational models of the brain — to simulate how the structure of the brain may impact brain activity and, ultimately, human behavior.READ MORE
8th Edition of International Conference and Exhibition on Separation Techniques
Jul 29 - Jul 30, 2019
International Women Health and Breast Cancer Conference
Jul 03 - Jul 05, 2019